[ad_1]
Kenvue Inc. (NYSE:KVUE) is included among the many 10 Greatest NYSE Dividend Shares to Purchase.
Kenvue Inc. (NYSE:KVUE) produces and sells client well being merchandise throughout a number of classes, together with over-the-counter medicines, private care, and wellness gadgets. Its portfolio options well-known family manufacturers resembling Tylenol for ache and fever aid, Neutrogena for skincare, and Listerine for oral hygiene.
Following its separation from Johnson & Johnson in 2023, Kenvue Inc. (NYSE:KVUE) has focused on utilizing digital instruments and client insights to strengthen model relevance. On the similar time, it’s working to modernize its provide chain and guarantee ongoing compliance with laws. Latest initiatives spotlight productiveness enhancements, stronger working margins, and selective investments in digital advertising and product innovation.
After its separation from Johnson & Johnson, Kenvue Inc. (NYSE:KVUE) inherited the standing of being acknowledged as a Dividend King. The corporate affords a quarterly dividend of $0.2075 per share, having raised it by 1.2% in July. With a dividend yield of 4.53%, as of September 20, KVUE is among the many finest dividend shares on our record.
Whereas we acknowledge the potential of KVUE as an funding, we imagine sure AI shares provide larger upside potential and carry much less draw back danger. For those who’re on the lookout for a particularly undervalued AI inventory that additionally stands to learn considerably from Trump-era tariffs and the onshoring pattern, see our free report on the finest short-term AI inventory.
READ NEXT: 12 Greatest Dividend Paying Shares to Purchase Now and 13 Extremely Low cost Dividend Shares to Make investments In.
Disclosure: None.
[ad_2]
